tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Surface Oncology's activity chart (see below) currently has 16 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.96% with an average time for these price targets to be met of 64.44 days.
Most recent stock forecast was given by from WEDBUSH on 20-Jun-2023. First documented stock forecast 14-May-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Aug-2020
$1.15
3 years 3 months 22 days ago
(20-Jun-2023)
1/5 (20%)
$0.36 (45.57%)
141
Buy Since 03-Nov-2022
$1
$-0.07 (-6.54%)
$6
3 years 3 months 22 days ago
(20-Jun-2023)
1/2 (50%)
$0.16 (19.05%)
20
Buy Since 04-Sep-2020
3 years 3 months 22 days ago
(20-Jun-2023)
1/3 (33.33%)
$4.77 (387.80%)
129
Buy Since 18-May-2021
$6
$4.93 (460.75%)
$17
3 years 11 months 9 days ago
(03-Nov-2022)
0/3 (0%)
$4.77 (387.80%)
Buy Since 14-May-2018
$26
$24.93 (2329.91%)
8 years 4 months 28 days ago
(14-May-2018)
0/1 (0%)
$12.61 (94.17%)
What is SURF (Surface Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on SURF (Surface Oncology)?
Which analyst has the current lower performing score on SURF (Surface Oncology) with a proven track record?
Which analyst has the most public recommendations on SURF (Surface Oncology)?
Which analyst is the currently most bullish on SURF (Surface Oncology)?
Which analyst is the currently most reserved on SURF (Surface Oncology)?
